| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. (DNLI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 46 sells. DNLI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 26.00M | $625.21M | - | |
| CEO | 296.8K | $7.14M | - | |
| Other | 282.8K | $6.80M | - | |
| Other | 216.6K | $5.21M | - | |
| Dir | 38.2K | $918.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 10, 2019 | Ho Carole73 | Chief Medical Officer | Sale+OE | 17,500 | $22.85 | $399,901.38 | -3.9% | |
| May 3, 2019 | Watts Ryan J.77 | President And CEO | Sell | 18,334 | $24.20 | $443,743.80 | -0.2% | |
| Apr 11, 2019 | Schuth Alexander O.75 | COO And Secretary | Sell | 7,500 | $28.05 | $210,395.89 | -0.4% | |
| Apr 4, 2019 | Ho Carole73 | Chief Medical Officer | Sell | 9,588 | $26.35 | $252,678.20 | -4.0% | |
| Apr 3, 2019 | Watts Ryan J.77 | President And CEO | Sell | 18,333 | $25.03 | $458,800.12 | -0.1% | |
| Apr 3, 2019 | Ho Carole73 | Chief Medical Officer | Sale+OE | 36,805 | $25.44 | $936,284.81 | -8.8% | |
| Mar 14, 2019 | Ho Carole73 | Chief Medical Officer | Sale+OE | 1,000 | $25.01 | $25,010.00 | -0.7% | |
| Mar 13, 2019 | Schuth Alexander O.75 | COO And Secretary | Sell | 7,500 | $22.58 | $169,313.16 | -0.2% | |
| Mar 5, 2019 | Ho Carole73 | Chief Medical Officer | Sale+OE | 17,500 | $22.17 | $388,000.33 | -83.1% | |
| Mar 5, 2019 | Watts Ryan J.77 | President And CEO | Sell | 18,333 | $22.18 | $406,600.81 | -0.1% |